Page 2 - Shimadzu Journal vol.9 Issue1

Note from the Director

Yoshiaki Mase
General Manager,
Analytical & Measurement Instruments Division

I am Yoshiaki Mase, the new General Manager of the globe. It has continued to develop mutations in-
the Analytical & Measuring Instruments Division. I termittently for more than a year now and is still
have replaced Shuzo Maruyama, who was ap- having a significant impact on the global economy.
pointed Managing Director of Shimadzu (Hong In order to mitigate the spread of this virus, it is im-
Kong) Ltd. in China this April. portant to have a diagnosis as quickly and easily as
Prior to this appointment, I worked as Managing possible in order to take suitable countermeasures
Director of Shimadzu (Hong Kong) Ltd. as the gen- at the earliest stage. As a quick and convenient virus
eral representative for Shimadzu’s business activities detection solution, Shimadzu released the 2019-
in China. At the same time, I pursued business activ- nCoV detection kit using our Ampdirect technology.
ities in the Chinese market as the Director/General In addition, we aim to contribute to suppressing
Manager of Shimadzu (China) Co., Ltd. While sta- COVID-19 by releasing the AutoAmp fully automatic
tioned in China, I helped transform the Shimadzu genetic analyzer.
China Mass Spectrometry Center in Beijing, a base The spread of this virus gives us a fresh aware-
for cooperative research in mass spectrometry tech- ness of just how much impact a new infectious dis-
nologies, into the China Innovation Center, and ad- ease can have on the world. Shimadzu’s current
justed the organization to enable cooperative medium-term management plan includes a project
research with customers utilizing technologies from to counter infectious diseases by utilizing a wide
a wider range of fields. range of technologies, including both our analytical/
At the China Innovation Center, we pursued spe- measuring technology and medical diagnostic imag-
cific measures for contributing to society through ing technology. Moving forward, we will continue to
science and technology. These measures included advance research and development to enable us to
research and development of revolutionary analyti- provide solutions as appropriate countermeasures.
cal methods in the ecology field and the clinical This edition of the Shimadzu Journal is a special
domain, and more recently, research and develop- edition on clinical research. It introduces case studies
ment of multiplex examination methods for multiple and applications of the use of Shimadzu analytical
human coronaviruses. instruments in the field of clinical research for the
This area of R&D has become all too timely with early detection of cancer and the analysis of antican-
the rapid spread of the COVID-19 coronavirus across cer agents and therapeutic drugs for COVID-19.

Shimadzu Journal vol.9 Issue1 1